India, Aug. 21 -- NeuroOne Medical Technologies Corporation (NMTC), a medical technology company focused on neurological disorders, recently reported fiscal third-quarter 2026 financial results, with product revenue rising 16% year over year to $2.0 million.
The company also highlighted stronger product orders, improved gross margins and progress across its brain ablation and drug delivery programs.
Q3 Financial Highlights:
Product revenue increased to $2.0 million from $1.7 million in the year-ago quarter, driven primarily by higher sales of OneRF products.
Product gross profit rose 29% to $1.2 million, while gross margin expanded to a record 59.9% from 53.9%.
The company received $2.7 million in product orders during the quarter, up ...